About
Advisor to Lightstone Ventures and President, CEO and co-founder of Tallac Therapeutics. Hong previously served as Chief Scientific Officer at ALX Oncology leading clinical advancement and held leadership positions at Pfizer and Wyeth Research across therapeutic areas.
Colleagues at Lightstone Ventures
Caroline Gaynor
Partner at Lightstone Ventures
Christina Isacson
Partner at Lightstone Ventures
Christina Isacson, Ph.D.
Partner at Lightstone Ventures
Doug Treco
Advisor at Lightstone Ventures
Doug Treco, Ph.D.
Advisor at Lightstone Ventures
Frank D. Lee
Advisor at Lightstone Ventures
H. Martin Seidel
Advisor at Lightstone Ventures
H. Martin Seidel, Ph.D.
Advisor at Lightstone Ventures
Frequently asked questions
- Who is Hong I. Wan, Ph.D.?
- Advisor to Lightstone Ventures and President, CEO and co-founder of Tallac Therapeutics. Hong previously served as Chief Scientific Officer at ALX Oncology leading clinical advancement and held leadership positions at Pfizer and Wyeth Research across therapeutic areas.
- Where does Hong I. Wan, Ph.D. work?
- Hong I. Wan, Ph.D. is Advisor at Lightstone Ventures.